Analyst firms · Robert W. Baird · SGFY
Robert W. Baird SGFY price target and rating history
Signify Health Inc. (SGFY) · Technology
Robert W. Baird rates Signify Health Inc. (SGFY) Outperform with a $16 price target, as of its latest action on May 16, 2022. It has published 3 rating actions on SGFY since September 2021, including 1 upgrade and 2 downgrades.
- Current rating
- Outperform
- Price target
- $16
- Median target, all firms
- Too few
- Actions on SGFY
- 3
Robert W. Baird price target on SGFY
Every Robert W. Baird rating on SGFY
- May 16, 2022
- Sep 23, 2021
- Sep 23, 2021
Questions about Robert W. Baird and SGFY
- What is Robert W. Baird's price target for SGFY?
- Robert W. Baird's latest stated price target for Signify Health Inc. (SGFY) is $16, from its action on May 16, 2022.
- What is Robert W. Baird's rating on SGFY?
- Robert W. Baird rates SGFY Outperform, a bullish rating, as of May 16, 2022.
- When did Robert W. Baird last change its view on SGFY?
- On May 16, 2022, Robert W. Baird upgrades to Outperform from Neutral, price target $19 to $16.
All Robert W. Baird ratingsSGFY news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.